A
Akadeum Life Sciences
Working on the problem of isolating mammalian and bacterial cells from complex mixtures
About Akadeum Life Sciences
Akadeum Life Sciences, Inc. specializes in advanced cell separation technology using proprietary microbubble technology. This innovative approach allows for rapid and gentle isolation of cells without the need for magnets, making it a valuable tool for researchers in clinical labs and other biotechnical roles. Akadeum's products are designed to improve the quality and reduce the costs of cell separation processes, which are crucial in various life sciences applications, including culture, PCR, and flow cytometry. The company operates in the biotechnology market and serves a diverse range of clients, including research institutions, clinical laboratories, and corporate partners. Akadeum generates revenue through the sale of its cell isolation products and by partnering with other companies to commercialize its microbubble-based technologies. The business model focuses on continuous innovation and collaboration to enhance cell separation workflows and results.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2014
- Headquarters
- Scio Township, United States
- Employees
- 15
- Open positions
- None listed
- Dealroom signal
- 62.8/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Aug 2026 | $0 | — | Undisclosed | ↗ |
| SERIES C✓Equity / VC | Jun 2026 | $2.1M | $8.5M | Undisclosed | ↗ |
Growth signals
Latest recorded traffic for Akadeum Life Sciences is 36K monthly website visits, up 0% over the last three months. Akadeum Life Sciences's team declined 31.8% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
ELab Ventures
Invest Detroit
Series A9 investors entered at this stage
Berkeley Catalyst Fund
Arboretum Ventures
Beringea
Agilent
Michigan Capital Network- LILifespan Investments
Michigan Rise
BlueStone Venture Partners
University of Michigan-Dearborn
Series B and later2 investors entered at this stage
Genoa Ventures
NYBC Ventures
Other known investors10 additional known investors
University of Michigan
Hemisphere Ventures
ID Ventures
Invest Michigan
Michigan Biomedical Venture Fund
Michigan State University Research Foundation
Northern Michigan Angels
Red Cedar Ventures
VisionTech Partners
Western Technology Investment
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Akadeum Life Sciences on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Akadeum Life Sciences’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.